A5111682607- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Lung Cancer Diagnosis and Treatment
- Cardiac Structural Anomalies and Repair
- Coronary Interventions and Diagnostics
- Aortic Disease and Treatment Approaches
- Cardiac Imaging and Diagnostics
- Lung Cancer Treatments and Mutations
- Radiomics and Machine Learning in Medical Imaging
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Global Cancer Incidence and Screening
- Coronary Artery Anomalies
- Cardiac Arrhythmias and Treatments
- Congenital Heart Disease Studies
- Migration, Policy, and Dickens Studies
- Advanced MRI Techniques and Applications
- Congenital Anomalies and Fetal Surgery
- Superconducting Materials and Applications
- Cardiac pacing and defibrillation studies
- Angiogenesis and VEGF in Cancer
- Cardiovascular Effects of Exercise
- Nanoparticle-Based Drug Delivery
- Medical Imaging Techniques and Applications
- Ultrasound in Clinical Applications
Université Laval
2013-2021
Lung Institute
2015-2020
Institut Universitaire de Cardiologie et de Pneumologie de Québec
2014-2019
Montreal Heart Institute
2013-2015
St. Paul's Hospital
2013
University of British Columbia
2013
Sunnybrook Health Science Centre
2009-2010
Health Sciences Centre
2009-2010
University of Toronto
2009-2010
Universidade Estadual de Campinas (UNICAMP)
1979
BackgroundCurrent lung cancer screening guidelines use either mean diameter, volume, or density of the largest nodule on previous CT scan appearance a new to ascertain timing next scan. We aimed develop an accurate protocol by estimating 3-year risk after two scans using deep learning radiologists' readings and other universally available clinical information.MethodsA algorithm (referred as DeepLR) was developed data from participants who had received at least up 2 years apart in National...
Plasma pro-surfactant protein B (pro-SFTPB) levels have recently been shown to predict the development of lung cancer in current and ex-smokers, but ability pro-SFTPB measures chronic obstructive pulmonary disease (COPD) severity is unknown. We evaluated performance characteristics as a biomarker function decline population ex-smokers. were measured 2503 ex-smokers enrolled Pan-Canadian Early Detection Lung Cancer Study. Linear regression was performed determine relationship changes forced...
Aims:The elastic behaviour (acute recoil) of a valve prosthesis stent following transcatheter aortic implantation (TAVI) is unknown.This study sought to determine the occurrence, severity, predictive factors and haemodynamic consequences acute recoil TAVI. Methods results:A prospective angiographic analysis frame dimensions in 111 consecutive patients who underwent TAVI with balloon-expandable (36 Edwards SAPIEN; 75 SAPIEN XT) was performed.Acute defined as difference between minimal lumen...
We sought to evaluate the position of balloon-expandable valves in relation coronary ostia using an angiographic- and computed tomography (CT)-based analysis, determine impact valve on angiography (CA)/percutaneous intervention (PCI) feasibility results.
Left atrial appendage aneurysm (LAAA) is a rare entity. Clinical manifestations include arrhythmias and systemic embolization. We show here an example of large ectopic LAAA mimicking mediastinal mass on chest X-ray presenting with incessant arrhythmias. Subsequent investigations leading to the correct diagnosis are described.
Very few data exist on coronary obstruction following transcatheter aortic valve implantation (TAVI) for degenerative bioprosthetic valves (valve-in-valve [ViV]). The present trial evaluated, through a systematic review of the literature, clinical characteristics, management and outcomes patients with after ViV-TAVI. Studies published between 2002 2013 evaluating as complication ViV-TAVI were identified using electronic search. Data procedural complication, analyzed. A total four...